Anesiva (Nasdaq: ANSV) is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. We have two product candidates in various stages of development.
Read more
 |
Zingo™ – A FAST ACTING LOCAL ANESTHETIC APPROVED BY THE FDA Zingo has been shown to provide local analgesia in 1 to 3 minutes prior to peripheral IV starts and blood draws in children three to 18 years of age. In clinical trials, the most common adverse reactions were redness (erythema), red dots (petechiae) and swelling (edema) at the site of administration. |
